Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Feb 4;6:20047. doi: 10.1038/srep20047

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2016, Macmillan Publishers Limited

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

(a) Distribution of invasive GBS CC17 isolates by age. CC17 isolates were primarily isolated from neonatal disease: 11% EOD (early-onset disease, 0–6 day old, dark blue); 44% LOD (late-onset disease, 7–89 days old, blue); 4% Ultra-LOD (>90 days old, light blue). One isolate was collected from a child (1%, depicted in orange). 40% of the isolates were collected from adult patients (>18 years, red). (b) Distribution of CC17 isolates by source of isolation. Most invasive CC17 GBS were isolated from blood (79, 85%). Additionally, there were six isolates from cerebrospinal fluid (CSF), three isolates from synovial fluid, two from tissue, and three strains isolated from other normally sterile sites.